Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.

NCT05708534 · clinicaltrials.gov ↗

RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant Infection

Interventions

DRUG: Belatacept

Sponsor

University Hospital, Rouen